Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Operating Income (2016 - 2025)

Historic Operating Income for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$7.2 million.

  • Jaguar Health's Operating Income rose 33.05% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.8 million, marking a year-over-year decrease of 857.4%. This contributed to the annual value of -$30.8 million for FY2024, which is 1009.01% up from last year.
  • As of Q3 2025, Jaguar Health's Operating Income stood at -$7.2 million, which was up 33.05% from -$8.0 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Operating Income peaked at -$6.3 million during Q4 2022, and registered a low of -$11.8 million during Q1 2022.
  • In the last 5 years, Jaguar Health's Operating Income had a median value of -$8.2 million in 2024 and averaged -$8.7 million.
  • As far as peak fluctuations go, Jaguar Health's Operating Income tumbled by 10944.46% in 2021, and later surged by 4405.01% in 2022.
  • Over the past 5 years, Jaguar Health's Operating Income (Quarter) stood at -$10.8 million in 2021, then surged by 41.91% to -$6.3 million in 2022, then decreased by 20.22% to -$7.6 million in 2023, then fell by 7.94% to -$8.2 million in 2024, then increased by 11.27% to -$7.2 million in 2025.
  • Its Operating Income stands at -$7.2 million for Q3 2025, versus -$8.0 million for Q2 2025 and -$9.4 million for Q1 2025.